Pintex Pharmaceuticals Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
Pintex Pharmaceuticals General Information
Description
Developer of novel cancer therapeutics and diagnostics. The company's research and development activity is based on the technology that originated at the Salk Institute for Biological Studies and at Harvard University.
Contact Information
Website
www.pintexpharm.comCorporate Office
- 313 Pleasant Street
- Watertown, MA 02472
- United States
Corporate Office
- 313 Pleasant Street
- Watertown, MA 02472
- United States
Pintex Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 01-Apr-2005 | Completed | Product Development | |||
| 3. Early Stage VC (Series B) | 07-May-2003 | Completed | Product Development | |||
| 2. Early Stage VC | 18-Apr-2002 | $1.1M | $4.1M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 01-Jan-2000 | $3M | $3M | Completed | Startup |
Pintex Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Pintex Pharmaceuticals Patents
Pintex Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2005094263-A2 | Methods of determining the prognosis and treatment of subjects with colon cancer | Inactive | 23-Mar-2004 | ||
| WO-2005094263-A3 | Methods of determining the prognosis and treatment of subjects with colon cancer | Inactive | 23-Mar-2004 | ||
| WO-2005076958-A2 | Methods of determining the prognosis and treatment of subjects with pin 1 associated disorders | Inactive | 05-Feb-2004 | ||
| WO-2005076958-A3 | Methods of determining the prognosis and treatment of subjects with pin 1 associated disorders | Inactive | 05-Feb-2004 | ||
| US-20050239095-A1 | Use of pin1 inhibitors for treatment of cancer | Inactive | 19-Sep-2003 | G01N33/57575 |
Pintex Pharmaceuticals Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioVentures Investors | Venture Capital | Minority | ||
| Canaan Partners | Venture Capital | Minority | ||
| Collaborative Seed & Growth Partners | Venture Capital | Minority | ||
| Pod Investment | Venture Capital | Minority | ||
| Zero Stage Capital | Venture Capital | Minority |
Pintex Pharmaceuticals FAQs
-
When was Pintex Pharmaceuticals founded?
Pintex Pharmaceuticals was founded in 1999.
-
Where is Pintex Pharmaceuticals headquartered?
Pintex Pharmaceuticals is headquartered in Watertown, MA.
-
What industry is Pintex Pharmaceuticals in?
Pintex Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Pintex Pharmaceuticals a private or public company?
Pintex Pharmaceuticals is a Private company.
-
What is Pintex Pharmaceuticals’s current revenue?
The current revenue for Pintex Pharmaceuticals is .
-
How much funding has Pintex Pharmaceuticals raised over time?
Pintex Pharmaceuticals has raised $11.7M.
-
Who are Pintex Pharmaceuticals’s investors?
BioVentures Investors, Canaan Partners, Collaborative Seed & Growth Partners, Pod Investment, and Zero Stage Capital have invested in Pintex Pharmaceuticals.
-
When was Pintex Pharmaceuticals acquired?
Pintex Pharmaceuticals was acquired on 01-Apr-2005.
-
Who acquired Pintex Pharmaceuticals?
Pintex Pharmaceuticals was acquired by Vernalis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process